Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy.
Saved in:
| Title: | Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy. |
|---|---|
| Authors: | Ho Sze Chan1 h.s.chan1982@gmail.com, de Blois, Erik1, Konijnenberg, Mark W.1, Morgenstern, Alfred2, Bruchertseifer, Frank2, Norenberg, Jeffrey P.3, Verzijlbergen, Fred J.1, de Jong, Marion1, Breeman, Wouter A. P.1 |
| Source: | EJNMMI Radiopharmacy & Chemistry. 5/14/2016, p1-15. 15p. |
| Database: | Academic Search Ultimate |
| ISSN: | 2365421X |
|---|---|
| DOI: | 10.1186/s41181-016-0014-4 |
